Zosano Pharma is a private pharmaceutical company focused on creating better products with their innovative drug delivery technology. Their lead program, parathyroid hormone (PTH) transdermal micro projection delivery system has finalized a Phase 2 clinical trial for treating severe osteoporosis. Zosano's objective is to discover and develop therapeutic drug candidates which address large unmet medical needs or have a significant potential for commercialization.